Tuesday, 01 July 2025
Experts from the 糖心原创 will investigate how genes responsible for disease and antifungal resistance might evolve and spread through fungal populations, thanks to funding from the Wellcome Trust.
Paul Dyer, a Professor in Fungal Biology in the School of Life Sciences has been awarded a £1.2million four-year grant to lead a team project including Dr Jasmine Ono from the University, along with researchers from the Universities of Manchester and Pretoria.
The project aims to investigate how genes responsible for human disease and antifungal resistance might evolve and spread through fungal populations by sexual and other transfer mechanisms, thereby providing an indication of risk from fungal diseases to inform future health management. The work also includes investigation of how climate change might impact on the evolution and spread of fungal pathogenicity genes.
The fungal diseases under study include life-threatening Aspergillosis and Candidiasis, and tropical Fusarium diseases. It is possible that sub populations of these fungi are already evolving to form new disease-causing species.
The research work will draw on recent developments in genomic, bioinformatic, gene editing and barcoding analyses which offer breakthrough possibilities.
Professor Dyer said: “Although many fungi are beneficial, there has been a recent rise in threats from fungal diseases to humans, animals and our plant food crops. This has been compounded by the evolution of resistance to the anti-fungals that we rely on to control disease.
“The funding from the Wellcome Trust will allow our team to study the mechanisms of how genes contributing to pathogenicity and drug resistance can evolve and spread through fungal populations, with associated risk, and how this might be impacted by climate change. This is critical to inform fungal disease management and future drug development. We are very grateful to Wellcome for providing us with this opportunity.”
Story credits
More information is available from Professor Paul Dyer at paul.dyer@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.